HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 2.600
+0.100 (4.00%)
Jul 31, 2026, 2:42 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.49 billion as of July 31, 2026. Its market cap has decreased by -25.50% in one year.
Market Cap
1.49B
Enterprise Value
1.13B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.60
ChartMarket Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.49B, a decrease of -76.69%. That is a compound annual growth rate of -42.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.49B | -11.86% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PegBio | 2.10B |
| SinoMab BioScience | 1.89B |
| AIM Vaccine | 1.77B |
| Mabpharm | 1.65B |
| Zhaoke Ophthalmology | 1.36B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.29B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.29B |
| Beijing Biostar Pharmaceuticals | 1.29B |